Bailout Includes New Restrictions on Drug Access
By Susan Brinkmann, OCDS
Staff Writer
Tucked inside the President’s $825 billion stimulus package is a plan to create a new government agency that will evaluate new medical drugs and products for their “cost effectiveness” before citizens can get access to them. The job of the new agency will be to determine the best way to “save money and lives” when it comes to costly health care problems such as cancer.
